Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on May 8, 2025
Ligand Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
First quarter performance driven by strong portfolio royalty revenue growth of 44% Strengthened commercial portfolio and pipeline through strategic transactions with Channel Therapeutics and Castle Creek Biosciences Reiterating 2025 financial guidance of $ …
Syndax Announces Participation in May Investor Conferences
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as …
Aptose Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
SAN DIEGO and TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat …
Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update
GlobeNewswire
·
May 8, 2025
RAP-219 Phase 2a trial in patients with refractory focal epilepsy remains on track with topline results expected in the third quarter of 2025 RAP-219 Phase 2a trial in patients with bipolar mania remains on track to commence in the third quarter of 2025, …
Entrada Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
– Receives regulatory authorization in the EU for ELEVATE-44-201, a Phase 1/2 MAD clinical study of ENTR-601-44 in patients living with Duchenne muscular dystrophy who are amenable to exon 44 skipping – – Company remains on track to initiate ELEVATE-44-201 …
Verano Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced its financial results for the first quarter ended March 31, 2025, which were …
Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.
GlobeNewswire
·
May 8, 2025
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation -Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint BRIDGEWATER, N.J., May 08, …
Liquidity Services Announces Second Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 8, 2025
BETHESDA, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), a leading global commerce company powering the circular economy, today announced its financial results for its fiscal quarter ended March 31, 2025, …
MAG Silver Reports First Quarter Financial Results
GlobeNewswire
·
May 8, 2025
VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) announces the Company’s unaudited consolidated financial results for the three months ended March 31, 2025 (“Q1 2025”). For …
Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
- Multiple Catalysts in Immuno-Inflammatory Indications Anticipated in 2025 and 2026 - - Expected Cash Runway Extended Through the First Half of 2028 - - Phase 2 Results Received to Date from Chinese Partner CTTQ Provide Clinical Evidence of Enhanced …
Blue Moon Metals Announces Start of Mobilization for Nussir Underground Development, Follow on Equity Investment of C$1.13M From Mining Contractor and Engagement of Market Maker
GlobeNewswire
·
May 8, 2025
TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce the mobilization of Leonhard Nilsen …
MAG Announces Second Dividend
GlobeNewswire
·
May 8, 2025
All amounts herein are reported in United States dollars (“US$”) unless otherwise specified VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) declares a fixed dividend of $0. …
ZA Miner führt Trump Coin ein, einen politisch inspirierten Token auf Ethereum-Basis
GlobeNewswire
·
May 8, 2025
Einblick in den Betrieb von ZA Miner: Unterstützung einer neuen Generation digitaler Vermögenswerte wie Trump Coin. MIDDLESEX, Vereinigtes Königreich, May 08, 2025 (GLOBE NEWSWIRE) -- ZA Miner, eine globale Plattform für den Handel mit digitalen …
Himax Technologies, Inc. Reports First Quarter 2025 Financial Results; Provides Second Quarter Guidance
GlobeNewswire
·
May 8, 2025
Q1 2025 Revenues At the High End of Projected Range, Gross Margin In-Line, EPS Exceeded Guidance Range Issued on February 13, 2025 Company Q2 2025 Guidance: Revenues to Decrease 5.0% to Increase 3.0% QoQ, Gross Margin is Expected to be Around 31.0%. Profit …
Biconomy.com Accelerates Toward Global Dominance in Crypto Trading
GlobeNewswire
·
May 8, 2025
DUBAI, United Arab Emirates, May 08, 2025 (GLOBE NEWSWIRE) -- Biconomy.com Exchange has unveiled an ambitious strategic roadmap aimed at securing its position as the dominant force in global crypto trading. With a laser focus on unlocking financial access …
Costamare Inc. Reports Results for the First Quarter Ended March 31, 2025
GlobeNewswire
·
May 8, 2025
MONACO, May 08, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the first quarter ended March 31, 2025 (“Q1 2025”). I. PROFITABILITY AND LIQUIDITY Q1 2025 Net Income …
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook
GlobeNewswire
·
May 8, 2025
First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable …
Esperion Partners with HLS Therapeutics to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Canada
GlobeNewswire
·
May 8, 2025
– Esperion to Receive an Upfront Payment, Near-Term Milestones and Tiered Royalties on Product Sales – – Further Expands Global Access to Bempedoic Acid Products and Provides Opportunity to Bring Innovative Preventative Therapy to 2.6 million Canadians …
Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
Awaiting FDA action on YUTREPIA™ NDA with a PDUFA goal date of May 24, 2025 District Court dismissed cross claim filed by United Therapeutics challenging PH-ILD amendment Fully enrolled Cohort A of ASCENT study in patients with PH-ILD Further strengthened …
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
GlobeNewswire
·
May 8, 2025
--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 -- --With positive Phase 2b …